These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1324 related articles for article (PubMed ID: 28549917)

  • 1. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models.
    Lu Z; Zuo B; Jing R; Gao X; Rao Q; Liu Z; Qi H; Guo H; Yin H
    J Hepatol; 2017 Oct; 67(4):739-748. PubMed ID: 28549917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro.
    Rao Q; Zuo B; Lu Z; Gao X; You A; Wu C; Du Z; Yin H
    Hepatology; 2016 Aug; 64(2):456-72. PubMed ID: 26990897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
    Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
    Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alarmin augments the antitumor immunity of lentiviral vaccine in ectopic, orthotopic and autochthonous hepatocellular carcinoma mice.
    Liu Z; Lu Z; Jing R; Zuo B; Gao X; Han G; Qi H; Wu L; Liu Y; Yin H
    Theranostics; 2019; 9(14):4006-4018. PubMed ID: 31281528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor efficacy of a hepatocellular carcinoma vaccine based on dendritic cells combined with tumor-derived autophagosomes in murine models.
    Su S; Zhou H; Xue M; Liu JY; Ding L; Cao M; Zhou ZX; Hu HM; Wang LX
    Asian Pac J Cancer Prev; 2013; 14(5):3109-16. PubMed ID: 23803088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses.
    Zuo B; Zhang Y; Zhao K; Wu L; Qi H; Yang R; Gao X; Geng M; Wu Y; Jing R; Zhou Q; Seow Y; Yin H
    J Hematol Oncol; 2022 Apr; 15(1):46. PubMed ID: 35488312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effects of human AFP-derived peptide-pulsed dendritic cells on mouse hepatocellular carcinoma].
    Pang XH; Chen MS; Jia WH; Zhou XX
    Ai Zheng; 2008 Dec; 27(12):1233-8. PubMed ID: 19079985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice.
    Bu N; Wu H; Zhang G; Zhan S; Zhang R; Sun H; Du Y; Yao L; Wang H
    J Mol Neurosci; 2015 Jul; 56(3):631-43. PubMed ID: 25680514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous Tumor Cell Lysate-Loaded Dendritic Cell Vaccine Inhibited Tumor Progression in an Orthotopic Murine Model for Hepatocellular Carcinoma.
    Wang Q; Luan W; Warren L; Kadri H; Kim KW; Goz V; Blank S; Isabel Fiel M; Hiotis SP
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):574-582. PubMed ID: 26786094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.
    Margalit M; Shibolet O; Klein A; Elinav E; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2005 Jun; 115(3):443-9. PubMed ID: 15688366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in mice.
    Cany J; Barteau B; Tran L; Gauttier V; Archambeaud I; Couty JP; Turlin B; Pitard B; Vassaux G; Ferry N; Conchon S
    J Hepatol; 2011 Jan; 54(1):115-21. PubMed ID: 20961645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antitumor efficacy through microwave ablation combined with a dendritic cell-derived exosome vaccine in hepatocellular carcinoma.
    Zhong X; Zhou Y; Cao Y; Ding J; Wang P; Luo Y; Liu H; Zhu Z; Jing X
    Int J Hyperthermia; 2020; 37(1):1210-1218. PubMed ID: 33100037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma.
    Hong Y; Peng Y; Guo ZS; Guevara-Patino J; Pang J; Butterfield LH; Mivechi NF; Munn DH; Bartlett DL; He Y
    Hepatology; 2014 Apr; 59(4):1448-58. PubMed ID: 24122861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice.
    Grimm CF; Ortmann D; Mohr L; Michalak S; Krohne TU; Meckel S; Eisele S; Encke J; Blum HE; Geissler M
    Gastroenterology; 2000 Oct; 119(4):1104-12. PubMed ID: 11040197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo.
    Chen Z; You L; Wang L; Huang X; Liu H; Wei JY; Zhu L; Qian W
    J Exp Clin Cancer Res; 2018 Aug; 37(1):190. PubMed ID: 30103789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
    Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
    Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of hepatocellular carcinoma growth via oral immune regulation towards tumor-associated antigens is associated with increased NKT and CD8+ lymphocytes.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Oncology; 2004; 66(4):323-30. PubMed ID: 15218301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Cell-associated Exosomes Robustly Elicit Anti-tumor Immune Responses through Modulating Dendritic Cell Vaccines in Lung Tumor.
    Wang C; Huang X; Wu Y; Wang J; Li F; Guo G
    Int J Biol Sci; 2020; 16(4):633-643. PubMed ID: 32025211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.